News for Imago BioSciences, Inc. (IMGO)

Fourth-Quarter and Full-Year Sales Reflect Sustained Growth Across Oncology and Vaccines Fourth-Quarter Worldwide Sales Were $14.6 Billion, an Increase of 6% From Fourth Quarter 2022; Excluding...

Sales Reflect Sustained Growth, Particularly in Oncology and Vaccines Total Worldwide Sales Were $16.0 Billion, an Increase of 7% From Third Quarter 2022; Excluding LAGEVRIO, Growth Was 6%;...

Visiongain has published a new report entitled Orphan Drugs Market Report 2023-2033: Forecasts by Therapeutic Area (Cancer, Neurological Diseases,...

/PRNewswire/ -- DelveInsight's Polycythemia Vera Market Insights report includes a comprehensive understanding of current treatment practices, polycythemia...

The worst banking crisis since 2008 could not stop the Fed from raising the benchmark interest rate. The possibility of further policy tightening and strict lending standards for banks might...

Karyopharm Therapeutics is significantly undervalued and recent progress is not being appreciated. Find out why KPTI stock is a Buy.

Merck has seen a significant valuation re-rating take place over the past years. This comes amidst the success of Keytruda which creates some dependency risks as well. Read more here.

Although headline inflation has slowed, the Fed will likely keep raising interest rates to attain its 2% target. However, a potential slowdown in monetary policy tightening is opening the path...

January 23, 2023 6:45 am ET RAHWAY, N.J., Jan. 23, 2023 - Merck , known as MSD outside of the United States and Canada, in the fourth quarter of 2022, announced the acquisition... | January 24, 2023

Is Merck stock a buy after Moderna said adding its cancer vaccine to Keytruda reduced the risk of relapse? Is MRK stock a buy now?

/PRNewswire/ -- Omega Funds, ein führendes internationales Unternehmen für Risikokapital im Gesundheitswesen, das sich darauf konzentriert, Patienten...

/PRNewswire/ -- Omega Funds, a leading international healthcare venture capital firm focused on delivering impactful medicines to patients, today announced it...